Growth Metrics

Madrigal Pharmaceuticals (MDGL) FCF Margin (2010 - 2026)

Madrigal Pharmaceuticals (MDGL) reported FCF Margin of 55.02% for Q1 2026, up 975.0% year-over-year from 5.12% in Q1 2025, and down 32.62% on a QoQ basis from 41.48% in Q4 2025.

Madrigal Pharmaceuticals (MDGL) has 6 years of FCF Margin data on file, last reported at 55.02% in Q1 2026.

  • Quarterly FCF Margin rose 975.0% year-over-year to 55.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24.05% (up 10085.0% YoY) and the FY2025 annual result came in at 19.83%, up 23389.0% from the prior year.
  • FCF Margin slipped to 55.02% in Q1 2026 per MDGL's latest filing, from 41.48% in the prior quarter.
  • Across five years, FCF Margin topped out at 27.54% in Q3 2025 and bottomed at 922.78% in Q2 2024.
  • The 3-year median for FCF Margin is 59.89% (2025), against an average of 161.01%.
  • The widest annual swing landed in 2025, when FCF Margin soared 90067 bps; it then jumped 975 bps in 2026.
  • Tracing MDGL's FCF Margin over 3 years: stood at 102.54% in 2024, then surged by 60 bps to 41.48% in 2025, then sank by 33 bps to 55.02% in 2026.
  • Per Business Quant, the three latest MDGL FCF Margin figures stand at 55.02% (Q1 2026), 41.48% (Q4 2025), and 27.54% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 43.35%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.17%
10 Madrigal Pharmaceuticals 14.44 Bn 14.20 Bn - -55.02%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -55.02%
Dec 31, 2025 -41.48%
Sep 30, 2025 27.54%
Jun 30, 2025 -22.11%
Mar 31, 2025 -64.77%
Dec 31, 2024 -102.54%
Sep 30, 2024 -106.95%
Jun 30, 2024 -922.78%
Mar 31, 2012 -10,476.87%
Dec 31, 2011 -317.50%
Sep 30, 2011 -2,319.39%
Jun 30, 2011 -5,776.78%
Mar 31, 2011 -1,124.15%
Dec 31, 2010 -204.09%
Sep 30, 2010 -251.11%